Tirzepatide was found to be more cost-effective than semaglutide when treating patients with knee osteoarthritis and…
Continue ReadingTag: costeffective
Tirzepatide More Cost-Effective Than Semaglutide for Obesity and Knee Osteoarthritis
Glucagon-like peptide-1 receptor agonist (GLP-1) tirzepatide is more cost-effective than semaglutide for patients with knee osteoarthritis…
Continue Reading
GLP-1 drugs may offer cost-effective treatment for people with knee osteoarthritis and obesity
A new study led by investigators at Mass General Brigham finds that adding novel weight loss…
Continue Reading